At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Jim Routt
Advertisement
Vice President and Unit Head, Oncology Global Therapeutic Delivery, IQVIA
Articles by Jim Routt
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
2025 SCRS Global Site Solutions Summit: How Technology Vendors Can Reduce Site Burden and Improve Trial Execution
3
AI in Action: Breaking Down Clinical Trial Bottlenecks
4
Focusing on Site Needs and Challenges: Quick Tips for Sponsors/CROs
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
